Private Placement

With ex-Sierra Space CEO Tom Vice at the helm, Astrion signals a bold new era, aiming to disrupt the national security and space markets.

Manufacturers are spending millions on ERP systems with poor results. Discover why a 'process-first' approach is becoming critical for survival and growth.

As the Final Four tips off, AI firm TISC hires NCAA champion 'Scooter' Barry to bridge the gap between high-tech analytics and coaching intuition.

With backing from Liberty Mutual, CenterNode aims to inject flexible capital into a market where traditional financing is scarce, accelerating the energy transition.

The data quality firm launches an autonomous system of AI agents designed to monitor, investigate, and act on data, aiming to redefine enterprise AI.

American Ventures publicizes support from 85+ investors, a move to counter a recent fraud lawsuit and an ongoing SEC investigation into its practices.

Dxcover's new AI platform uses infrared light to detect early-stage colorectal, pancreatic, and ovarian cancers from blood with unprecedented sensitivity.

A $10M investment from BVF Partners propels Entera Bio’s revolutionary oral osteoporosis drug into a pivotal Phase 3 trial, a major step for patients.

A pivotal clinical trial for PMM2-CDG, a devastating genetic disorder with no approved treatments, has completed enrollment, offering hope to thousands.

With $10M from ATEL Ventures, Carbon Upcycling is set to commercialize its breakthrough tech, turning CO2 and industrial waste into green building materials.

IFF targets the booming pet wellness market with PureStrong™, a probiotic built from canine science. Is this the future of dog digestive health?

A $2B facility aims to turn wood waste into clean power while burying carbon, a project that could provide an economic lifeline and reshape the energy grid.

A Utah fintech just landed a massive credit line to disrupt the luxury auto market. Here's how its AI platform is changing the game for car collectors.

AvenCell has dosed the first patient with AVC-203, a novel allogeneic CAR-T therapy, aiming to make advanced cancer treatment more accessible and effective.

Geely-backed CaoCao Inc. is the first to get approval for unmanned Robotaxi testing in Hangzhou, accelerating the race against rivals like Baidu and WeRide.

Wheaton Precious Metals enters Australia with a landmark streaming deal, funding KGL's Jervois copper mine and tapping into critical metals for the green economy.

Riding the wave of an Oprah endorsement, D2C powerhouse GOAT Foods lands a strategic credit facility to refinance debt and accelerate its rapid growth.

Texan by Nature names its 2026 Conservation Wranglers, backing innovative projects from desert creeks to urban cemeteries to secure the state's future.

With a new technical report filed, Aventis Energy outlines its exploration strategy for the promising Sting Copper Project in a resource-rich region.

In a tough biotech market, NewcelX's $1.35M financing at a 30% premium signals strong confidence in its pioneering stem cell therapy for Type 1 Diabetes.